Clinical Trial Update: Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is assessing the effects of SGLT2 inhibitors on kidney function in adults with advanced chronic kidney disease (CKD stage 4-5) and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Ain Shams University | Conditions: Chronic Kidney Disease Stage 5, CKD Stage 4 | Phase 3 | Status: RECRUITING